ストックスクリーナーアプリを入手
37.91
3.27%
-1.28
アフターアワーズ：
38.10
0.19
+0.50%
前日終値:
$39.19
開ける：
$39.43
24時間の取引高:
1.79M
Relative Volume:
0.83
時価総額：
$6.02B
収益：
$264.79M
当期純損益:
$-14.36M
株価収益率:
-344.64
EPS:
-0.11
ネットキャッシュフロー:
$-28.11M
1週間 パフォーマンス:
+2.22%
1か月 パフォーマンス:
+7.81%
6か月 パフォーマンス:
+28.29%
1年 パフォーマンス:
+78.57%
1日の値動き範囲:
$37.66
$39.54
1週間の範囲:
$36.50
$39.73
52週間の値動き範囲:
$16.65
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
名前
Tg Therapeutics Inc
セクター
電話
(212) 554-4484
住所
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
TGTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
37.91 | 5.89B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
459.81 | 120.40B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
542.52 | 61.30B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.53 | 41.06B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
564.59 | 34.29B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.55 | 27.09B | 3.81B | -644.79M | -669.77M | -6.24 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-10 | 再開されました | Goldman | Neutral |
| 2024-10-29 | 開始されました | TD Cowen | Buy |
| 2023-08-02 | アップグレード | Goldman | Sell → Neutral |
| 2023-06-26 | 再開されました | Jefferies | Buy |
| 2022-05-20 | 開始されました | BofA Securities | Underperform |
| 2022-02-23 | 繰り返されました | B. Riley Securities | Buy |
| 2021-11-15 | ダウングレード | Goldman | Neutral → Sell |
| 2021-04-20 | 開始されました | Goldman | Neutral |
| 2021-04-19 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-01 | 開始されました | JP Morgan | Overweight |
| 2020-08-11 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-05 | 開始されました | Evercore ISI | Outperform |
| 2020-01-17 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-11-27 | 再開されました | B. Riley FBR | Buy |
| 2019-02-06 | 再開されました | Jefferies | Buy |
| 2018-09-25 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | 繰り返されました | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | 再開されました | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | 再開されました | H.C. Wainwright | Buy |
| 2017-04-25 | 開始されました | Jefferies | Buy |
| 2017-03-06 | 繰り返されました | FBR & Co. | Outperform |
| 2016-10-06 | 再開されました | Brean Capital | Buy |
| 2016-05-27 | 開始されました | SunTrust | Buy |
| 2015-12-01 | 開始されました | FBR Capital | Outperform |
| 2015-09-09 | 開始されました | Raymond James | Strong Buy |
| 2015-08-12 | 再開されました | H.C. Wainwright | Buy |
| 2015-06-19 | 繰り返されました | Brean Capital | Buy |
| 2014-12-11 | 繰り返されました | ROTH Capital | Buy |
| 2014-12-10 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Tg Therapeutics Inc (TGTX) 最新ニュース
TG Therapeutics Inc. Stock Analysis and ForecastRemarkable growth - Jammu Links News
Is TG Therapeutics Inc. a good long term investmentFree Market Dynamics Reports - Jammu Links News
How To Trade (TGTX) - news.stocktradersdaily.com
What analysts say about TG Therapeutics Inc. stockExplosive capital gains - Jammu Links News
TG Therapeutics Joins Rank Of Stocks With RS Ratings Over 90 - MSN
A Note On TG Therapeutics, Inc.'s (NASDAQ:TGTX) ROE and Debt To Equity - simplywall.st
Goldman Sachs resumes TG Therapeutics stock coverage with Neutral rating By Investing.com - Investing.com Canada
We Think TG Therapeutics (NASDAQ:TGTX) Can Stay On Top Of Its Debt - 富途牛牛
Cramer's Lightning Round: TG Therapeutics is a buy - MSN
Jim Cramer on TG Therapeutics: “You Should Buy the Stock” - MSN
SHAREHOLDER COMPLAINT: Levi & Korsinsky LLP Files Case in U.S. District Court to Recover Losses Suffered By Investors in TG Therapeutics, Inc.Sets Lead Plaintiff Deadline of March 7, 2017 - ACCESS Newswire
14 Stocks Jim Cramer Recently Looked At - Insider Monkey
Cramer Backs This Mining Giant After $1.6B Bet - Benzinga
TG Therapeutics: Cramer's Bullish Call Amid Clinical Pipeline Potential - AInvest
TG Therapeutics: Strong Execution Tempered By An Evolving Market (NASDAQ:TGTX) - Seeking Alpha
Long Term Trading Analysis for (TGTX) - news.stocktradersdaily.com
TG Therapeutics: Another Possible Avenue Of MS Growth With Azer-Cel (NASDAQ:TGTX) - Seeking Alpha
Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance
Have Insiders Sold TG Therapeutics Shares Recently? - simplywall.st
Insider Selling: Yann Echelard Unloads $369K Of TG Therapeutics Stock - Nasdaq
Tg therapeutics director Yann Echelard sells $369,400 in stock - Investing.com Australia
(TGTX) Trading Advice - news.stocktradersdaily.com
Tg therapeutics director Yann Echelard sells $369,400 in stock By Investing.com - Investing.com Canada
TGTX Experiences Surge in Bullish Options Activity | TGTX Stock News - GuruFocus
Are Options Traders Betting on a Big Move in TG Therapeutics Stock? - Yahoo Finance
TG Therapeutics shareholders approve key proposals By Investing.com - Investing.com South Africa
TG Therapeutics Approves Key Proposals at Annual Meeting - TipRanks
TG Therapeutics shareholders approve key proposals - Investing.com
TG Therapeutics at Goldman Sachs Conference: Strategic Growth and Innovations - Investing.com Canada
Transcript : TG Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - marketscreener.com
GAMMA Investing LLC Purchases 176,573 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference | TGTX Stock News - GuruFocus
TG Therapeutics (NasdaqCM:TGTX) Stock Rises 13% In Last Month - Yahoo
Kalkine: TG Therapeutics Schedules Fireside Chat at Goldman Sachs Conference Amid FT100 Futures Focus - Kalkine Media
TG Therapeutics CEO Fireside Chat at Goldman's Premier Healthcare Conference: Key Updates Coming - Stock Titan
Two Sigma Advisers LP Sells 214,800 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
LAWSUITS FILED AGAINST U, TGTX and CVNAJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Transcript : TG Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 12 - marketscreener.com
(TGTX) Investment Analysis and Advice - news.stocktradersdaily.com
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference - The Manila Times
TG Therapeutics CEO Fireside Chat: Key Updates Expected at Major Healthcare Conference - Stock Titan
TG Therapeutics shares MS drug trial updates By Investing.com - Investing.com South Africa
TG Therapeutics Announces Data Presentations for BRIUMVI in Mult - GuruFocus
TG Therapeutics shares MS drug trial updates - Investing.com
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus
Tg Therapeutics Inc (TGTX) 財務データ
収益
当期純利益
現金流量
EPS
0.59%
0.34%
大文字化:
|
ボリューム (24 時間):